$2.80

+0.03 (+1.08%)

Weekly Expected Move ±10.3%

$2 $3 $3 $3 $3

NYSE · Healthcare · Medical - Care Facilities · Alpha Radar Sell · Power 39 · $394.6M mcap · 110M float · 1.51% daily turnover · Short 70% of daily vol

Revenue Segmentation

By Product / Service

Revenue by Segment (5-Year Trend)

Income Trends

Revenue

$12.5B -1.2% ▼

5Y CAGR: +1.2%

Gross Profit

$1.1B -79.5% ▼

5Y CAGR: -24.5%

Operating Income

-$9.9B -1929.3% ▼

Net Income

$509M +198.6% ▲

5Y CAGR: -0.1%

EPS (Diluted)

$3.77 +196.7% ▲

5Y CAGR: -3.0%

EBITDA

$2.0B +61.7% ▲

5Y CAGR: +14.9%

Profit Margins

Year-over-Year Growth

View Full Income Statement

Line Item	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$12.4B	$12.2B	$12.5B	$12.6B	$12.5B
YoY Growth	+4.9%	-1.3%	+2.3%	+1.2%	-1.2%
Cost of Revenue	$7.3B	$7.3B	$7.4B	$7.4B	$11.4B
Gross Profit	$5.1B	$4.9B	$5.1B	$5.3B	$1.1B
Gross Margin	41.1%	40.2%	40.7%	41.7%	8.7%
R&D Expenses	$108M	$85M	$80M	$0	$0
SG&A Expenses	$308M	$317M	$319M	$299M	$0
Operating Expenses	$3.7B	$4.1B	$4.1B	$4.7B	$11.0B
Operating Income	$1.4B	$821M	$957M	$542M	-$9.9B
Operating Margin	11.3%	6.7%	7.7%	4.3%	-79.4%
Interest Expense	$885M	$858M	$832M	$863M	$870M
Income Before Tax	$499M	$349M	$207M	-$283M	$724M
Tax Expense	$131M	$170M	$191M	$79M	$48M
Net Income	$230M	$46M	-$133M	-$516M	$509M
Net Margin	1.9%	0.4%	-1.1%	-4.1%	4.1%
EPS (Diluted)	$1.76	$0.35	$-1.02	$-3.90	$3.77
EBITDA	$1.7B	$1.2B	$1.3B	$1.2B	$2.0B
Shares Outstanding	131M	130M	130M	132M	135M

Line Item	FY2024 Q2	FY2024 Q3	FY2024 Q4	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1
Revenue	$3.1B	$3.1B	$3.3B	$3.2B	$3.1B	$3.1B	$3.1B	$12.2B
Cost of Revenue	$1.8B	$1.8B	$1.9B	$1.9B	$1.8B	$460M	$7.3B	$413M
Gross Profit	$1.3B	$1.3B	$1.4B	$1.3B	$1.3B	$2.6B	-$4.2B	$11.7B
Gross Margin	42.3%	40.8%	42.7%	41.1%	42.7%	85.1%	-134.6%	96.6%
R&D Expenses	$0	$0	$0	$0	$0	$0	$0	$0
SG&A Expenses	$73M	$73M	$75M	$68M	$74M	$1.4B	-$1.6B	$10.7B
Operating Expenses	$1.1B	$1.5B	$1.1B	$1.0B	$825M	$2.4B	$6.8B	$10.1B
Operating Income	$238M	-$205M	$278M	$284M	$512M	$243M	-$11.0B	$1.6B
Operating Margin	7.6%	-6.6%	8.5%	9.0%	16.3%	7.9%	-352.7%	13.5%
Interest Expense	$216M	$216M	$217M	$219M	$214M	$216M	$221M	$213M
Income Before Tax	$50M	-$419M	$64M	$67M	$438M	-$2M	$221M	-$880M
Tax Expense	$24M	-$64M	$92M	$42M	$118M	-$173M	$61M	$102M
Net Income	-$13M	-$391M	-$70M	-$13M	$282M	$130M	$110M	-$610M
Net Margin	-0.4%	-12.7%	-2.1%	-0.4%	9.0%	4.2%	3.5%	-5.0%
EPS (Diluted)	$-0.10	$-2.95	$-0.53	$-0.10	$2.09	$0.96	$0.82	$-4.52
EBITDA	$374M	$178M	$334M	$365M	$379M	$322M	$549M	$3.7B
Shares Outstanding	132M	132M	132M	133M	135M	135M	135M	135M

CYH NYSE